Open Access

Erratum to: NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin

  • Dong Suwei1, 2,
  • Zeng Liang3,
  • Liu Zhimin2,
  • Li Ruilei2,
  • Zou Yingying4,
  • Li Zhen1, 2,
  • Ge Chunlei2,
  • Lai Zhangchao2,
  • Xue Yuanbo2,
  • Yang Jinyan2,
  • Li Gaofeng5 and
  • Song Xin1, 2Email author
Journal of Hematology & Oncology20169:11

https://doi.org/10.1186/s13045-016-0239-4

Published: 17 February 2016

The original article was published in Journal of Hematology & Oncology 2015 8:120

Erratum

Following the publication of this article [1], the authors noticed that the text contained an error. Within the text ‘TLF4’ should be ‘KLF4’.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Cancer Research Institute of Southern Medical University
(2)
Department of Cancer Biotherapy Center, The Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province)
(3)
Department of Pathology, Hunan Tumor Hospital
(4)
Department of Pathology and Pathophysiology, Kunming Medical University
(5)
Department of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), Kunming

Reference

  1. Song X et al. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin. J Hematol Oncol. 2015;8:120.View ArticleGoogle Scholar

Copyright

© Suwei et al. 2016

Advertisement